Logo image of NXP

NUVEEN SELECT TAX-FREE INC (NXP) Stock Price, Quote, News and Overview

NYSE:NXP - New York Stock Exchange, Inc. - US67062F1003 - Currency: USD

13.94  +0.11 (+0.8%)

Fundamental Rating

3

Overall NXP gets a fundamental rating of 3 out of 10. We evaluated NXP against 0 industry peers in the Unkown industry. NXP has a bad profitability rating. Also its financial health evaluation is rather negative. NXP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NXP had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: NXP reported negative net income in multiple years.
NXP had a negative operating cash flow in each of the past 5 years.
NXP Yearly Net Income VS EBIT VS OCF VS FCFNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

1.2 Ratios

The last Return On Invested Capital (3.36%) for NXP is above the 3 year average (2.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.68%
ROE 3.76%
ROIC 3.36%
ROA(3y)0.18%
ROA(5y)2.33%
ROE(3y)0.18%
ROE(5y)2.34%
ROIC(3y)2.39%
ROIC(5y)2.59%
NXP Yearly ROA, ROE, ROICNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 6 -6

1.3 Margins

NXP's Operating Margin has been stable in the last couple of years.
NXP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 94.74%
PM (TTM) 83.36%
GM 95.29%
OM growth 3Y0.14%
OM growth 5Y0.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
NXP Yearly Profit, Operating, Gross MarginsNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

NXP has about the same amout of shares outstanding than it did 1 year ago.
NXP has more shares outstanding than it did 5 years ago.
NXP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXP Yearly Shares OutstandingNXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NXP Yearly Total Debt VS Total AssetsNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

NXP has an Altman-Z score of 28.58. This indicates that NXP is financially healthy and has little risk of bankruptcy at the moment.
NXP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 28.58
ROIC/WACCN/A
WACCN/A
NXP Yearly LT Debt VS Equity VS FCFNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.07 indicates that NXP should not have too much problems paying its short term obligations.
NXP has a Quick Ratio of 1.07. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
NXP Yearly Current Assets VS Current LiabilitesNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.45% over the past year.
NXP shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.93%.
The Revenue has been growing by 20.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)125.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.82%
Revenue 1Y (TTM)38.93%
Revenue growth 3Y35.45%
Revenue growth 5Y20.68%
Sales Q2Q%35.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXP Yearly Revenue VS EstimatesNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NXP is valuated quite expensively with a Price/Earnings ratio of 26.30.
NXP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.78.
Industry RankSector Rank
PE 26.3
Fwd PE N/A
NXP Price Earnings VS Forward Price EarningsNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXP Per share dataNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

NXP has a Yearly Dividend Yield of 4.10%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.46, NXP pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.1%

5.2 History

NXP has been paying a dividend for at least 10 years, so it has a reliable track record.
NXP has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years7
NXP Yearly Dividends per shareNXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NXP Yearly Income VS Free CF VS DividendNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

More info and screens

NUVEEN SELECT TAX-FREE INC

NYSE:NXP (4/25/2025, 8:04:00 PM)

13.94

+0.11 (+0.8%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-02 2024-12-02
Earnings (Next)N/A N/A
Inst Owners17.31%
Inst Owner Change1.08%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap685.57M
Analysts45
Price TargetN/A
Short Float %0.11%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 4.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years7
Ex-Date04-15 2025-04-15 (0.052)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.3
Fwd PE N/A
P/S 23.35
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)0.53
EY3.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.6
BVpS13.23
TBVpS13.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.68%
ROE 3.76%
ROCE 4.25%
ROIC 3.36%
ROICexc 3.36%
ROICexgc 3.36%
OM 94.74%
PM (TTM) 83.36%
GM 95.29%
FCFM N/A
ROA(3y)0.18%
ROA(5y)2.33%
ROE(3y)0.18%
ROE(5y)2.34%
ROIC(3y)2.39%
ROIC(5y)2.59%
ROICexc(3y)2.39%
ROICexc(5y)2.6%
ROICexgc(3y)2.4%
ROICexgc(5y)2.6%
ROCE(3y)3.02%
ROCE(5y)3.28%
ROICexcg growth 3Y-1.48%
ROICexcg growth 5Y-1.18%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-1.18%
OM growth 3Y0.14%
OM growth 5Y0.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 28.58
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.93%
Revenue growth 3Y35.45%
Revenue growth 5Y20.68%
Sales Q2Q%35.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.91%
EBIT growth 3Y35.64%
EBIT growth 5Y20.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A